{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:26:28Z","timestamp":1787019988703,"version":"build-2736575974"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T00:00:00Z","timestamp":1539561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004595","name":"Universiti Sains Malaysia","doi-asserted-by":"publisher","award":["University research grant (1001\/PFarmasi\/811285)"],"award-info":[{"award-number":["University research grant (1001\/PFarmasi\/811285)"]}],"id":[{"id":"10.13039\/501100004595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nanoscale Res Lett"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s11671-018-2744-6","type":"journal-article","created":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T10:33:29Z","timestamp":1539599609000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Lyophilized Hybrid Nanostructured Lipid Carriers to Enhance the Cellular Uptake of Verapamil: Statistical Optimization and In Vitro Evaluation"],"prefix":"10.1186","volume":"13","author":[{"given":"Arshad Ali","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim M.","family":"Abdulbaqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem","family":"Abou Assi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikneswaran","family":"Murugaiyah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusrida","family":"Darwis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,15]]},"reference":[{"issue":"2","key":"2744_CR1","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jpba.2004.11.003","volume":"37","author":"OH Jhee","year":"2005","unstructured":"Jhee OH, Hong JW, Om AS, Lee MH, Lee WS, Shaw LM et al (2005) Direct determination of verapamil in rat plasma by coupled column microbore-HPLC method. J Pharm Biomed Anal 37(2):405\u2013410","journal-title":"J Pharm Biomed Anal"},{"issue":"3","key":"2744_CR2","doi-asserted-by":"publisher","first-page":"FSO135","DOI":"10.4155\/fsoa-2016-0030","volume":"2","author":"N Poonia","year":"2016","unstructured":"Poonia N, Kharb R, Lather V, Pandita D (2016) Nanostructured lipid carriers: versatile oral delivery vehicle. Future Sci OA 2(3):FSO135","journal-title":"Future Sci OA"},{"key":"2744_CR3","first-page":"2733","volume":"8","author":"A Ali Khan","year":"2013","unstructured":"Ali Khan A, Mudassir J, Mohtar N, Darwis Y (2013) Advanced drug delivery to the lymphatic system: lipid-based nanoformulations. Int J Nanomedicine 8:2733\u20132744","journal-title":"Int J Nanomedicine"},{"issue":"12","key":"2744_CR4","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1211\/0022357044959","volume":"56","author":"L Hu","year":"2004","unstructured":"Hu L, Tang X, Cui F (2004) Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs. J Pharm Pharmacol 56(12):1527\u20131535","journal-title":"J Pharm Pharmacol"},{"issue":"2","key":"2744_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0378-5173(00)00378-1","volume":"199","author":"V Jenning","year":"2000","unstructured":"Jenning V, Thunemann AF, Gohla SH (2000) Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids. Int J Pharm 199(2):167\u2013177","journal-title":"Int J Pharm"},{"issue":"3\u20134","key":"2744_CR6","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.colsurfb.2005.08.005","volume":"45","author":"FQ Hu","year":"2005","unstructured":"Hu FQ, Jiang SP, Du YZ, Yuan H, Ye YQ, Zeng S (2005) Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloids Surf B Biointerfaces 45(3\u20134):167\u2013173","journal-title":"Colloids Surf B Biointerfaces"},{"key":"2744_CR7","doi-asserted-by":"publisher","first-page":"5449","DOI":"10.2147\/IJN.S73010","volume":"9","author":"RN Shamma","year":"2014","unstructured":"Shamma RN, Aburahma MH (2014) Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia. Int J Nanomedicine 9:5449\u20135460","journal-title":"Int J Nanomedicine"},{"issue":"9","key":"2744_CR8","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1111\/j.1745-7254.2008.00829.x","volume":"29","author":"H Z-r","year":"2008","unstructured":"Z-r H, S-c H, Y-l Y, J-y F (2008) Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion. Acta Pharmacol Sin 29(9):1094\u20131102","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"2744_CR9","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.colsurfb.2011.07.036","volume":"88","author":"S Das","year":"2011","unstructured":"Das S, Ng WK, Kanaujia P, Kim S, Tan RB (2011) Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables. Colloids Surf B Biointerfaces. 88(1):483\u2013489","journal-title":"Colloids Surf B Biointerfaces."},{"issue":"1\u20132","key":"2744_CR10","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ijpharm.2010.05.005","volume":"394","author":"CY Zhuang","year":"2010","unstructured":"Zhuang CY, Li N, Wang M, Zhang XN, Pan WS, Peng JJ et al (2010) Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability. Int J Pharm 394(1\u20132):179\u2013185","journal-title":"Int J Pharm"},{"issue":"3","key":"2744_CR11","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0939-6411(98)00004-6","volume":"45","author":"F Franks","year":"1998","unstructured":"Franks F (1998) Freeze-drying of bioproducts: putting principles into practice. Eur J Pharm Biopharm 45(3):221\u2013229","journal-title":"Eur J Pharm Biopharm"},{"issue":"4","key":"2744_CR12","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.carbpol.2012.01.051","volume":"88","author":"J Varshosaz","year":"2012","unstructured":"Varshosaz J, Eskandari S, Tabbakhian M (2012) Freeze-drying of nanostructure lipid carriers by different carbohydrate polymers used as cryoprotectants. Carbohydr Polym 88(4):1157\u20131163","journal-title":"Carbohydr Polym"},{"key":"2744_CR13","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1146\/annurev.ph.54.030192.003051","volume":"54","author":"JH Crowe","year":"1992","unstructured":"Crowe JH, Hoekstra FA, Crowe LM (1992) Anhydrobiosis. Annu Rev Physiol 54:579\u2013599","journal-title":"Annu Rev Physiol"},{"issue":"4","key":"2744_CR14","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1016\/S0006-3495(96)79407-9","volume":"71","author":"LM Crowe","year":"1996","unstructured":"Crowe LM, Reid DS, Crowe JH (1996) Is trehalose special for preserving dry biomaterials? Biophys J 71(4):2087\u20132093","journal-title":"Biophys J"},{"issue":"46","key":"2744_CR15","doi-asserted-by":"publisher","first-page":"10243","DOI":"10.1021\/jp984736i","volume":"103","author":"D Miller","year":"1999","unstructured":"Miller D, de Pablo J, Corti H (1999) Viscosity and glass transition temperature of aqueous mixtures of trehalose with borax and sodium chloride. J Phys Chem B 103(46):10243\u201310249","journal-title":"J Phys Chem B"},{"issue":"2","key":"2744_CR16","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.nano.2011.06.007","volume":"8","author":"P Zhang","year":"2012","unstructured":"Zhang P, Ling G, Pan X, Sun J, Zhang T, Pu X et al (2012) Novel nanostructured lipid-dextran sulfate hybrid carriers overcome tumor multidrug resistance of mitoxantrone hydrochloride. Nanomedicine 8(2):185\u2013193","journal-title":"Nanomedicine"},{"issue":"8","key":"2744_CR17","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1007\/s11095-006-9033-2","volume":"23","author":"Y Li","year":"2006","unstructured":"Li Y, Taulier N, Rauth AM, Wu XY (2006) Screening of lipid carriers and characterization of drug-polymer-lipid interactions for the rational design of polymer-lipid hybrid nanoparticles (PLN). Pharm Res 23(8):1877\u20131887","journal-title":"Pharm Res"},{"key":"2744_CR18","first-page":"103","volume-title":"The impact of food bioactives on health: in vitro and ex vivo models","author":"T Lea","year":"2015","unstructured":"Lea T (2015) Caco-2 Cell Line. In: Verhoeckx K, Cotter P, L\u00f3pez-Exp\u00f3sito I, Kleiveland C, Lea T, Mackie A et al (eds) The impact of food bioactives on health: in vitro and ex vivo models. Springer International Publishing, Cham, pp 103\u2013111"},{"issue":"7","key":"2744_CR19","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3109\/10837450.2014.938857","volume":"20","author":"Mansi K. Shah","year":"2014","unstructured":"Shah MK, Madan P, Lin S (2014) Elucidation of intestinal absorption mechanism of carvedilol-loaded solid lipid nanoparticles using Caco-2 cell line as an in-vitro model. Pharm Dev Technol 20(7):\u200b877\u2013885\u00a0","journal-title":"Pharmaceutical Development and Technology"},{"key":"2744_CR20","doi-asserted-by":"publisher","unstructured":"Cortes-Rojas DF, Souza CRF, Chen MJ, Hochhaus G, Oliveira WP (2017) Effects of lipid formulations on clove extract spray dried powders: comparison of physicochemical properties, storage stability and in vitro intestinal permeation. Pharm Dev Technol (\n                    https:\/\/doi.org\/10.1080\/10837450.2017.1314491\n                    \n                  )","DOI":"10.1080\/10837450.2017.1314491"},{"key":"2744_CR21","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.2217\/nnm.12.99","volume":"7","author":"BH Kenzaoui","year":"2012","unstructured":"Kenzaoui BH, Vila MR, Miquel JM, Cengelli F, Juillerat-Jeanneret L (2012) Evaluation of uptake and transport of cationic and anionic ultrasmall iron oxide nanoparticles by human colon cells. Int J Nanomedicine 7:1275\u20131286","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"2744_CR22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/1091581814560032","volume":"34","author":"Y Cao","year":"2015","unstructured":"Cao Y, Roursgaard M, Kermanizadeh A, Loft S, Moller P (2015) Synergistic effects of zinc oxide nanoparticles and fatty acids on toxicity to caco-2 cells. Int J Toxicol 34(1):67\u201376","journal-title":"Int J Toxicol"},{"issue":"4","key":"2744_CR23","first-page":"304","volume":"67","author":"L Zhou","year":"2012","unstructured":"Zhou L, Chen Y, Zhang Z, He J, Du M, Wu Q (2012) Preparation of tripterine nanostructured lipid carriers and their absorption in rat intestine. Pharmazie 67(4):304\u2013310","journal-title":"Pharmazie"},{"issue":"3","key":"2744_CR24","doi-asserted-by":"publisher","first-page":"1600053","DOI":"10.1002\/ejlt.201600053","volume":"119","author":"Y Sangsen","year":"2017","unstructured":"Sangsen Y, Wiwattanawongsa K, Likhitwitayawuid K, Sritularak B, Wiwattanapatapee R (2017) Comparisons between a self-microemulsifying system and lipid nanoparticles of oxyresveratrol on the physicochemical properties and Caco-2 cell permeability. Eur J Lipid Sci Technol 119(3):1600053","journal-title":"Eur J Lipid Sci Technol"},{"issue":"1","key":"2744_CR25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ijpharm.2014.11.017","volume":"478","author":"LL Shi","year":"2015","unstructured":"Shi LL, Cao Y, Zhu XY, Cui JH, Cao QR (2015) Optimization of process variables of zanamivir-loaded solid lipid nanoparticles and the prediction of their cellular transport in Caco-2 cell model. Int J Pharm 478(1):60\u201369","journal-title":"Int J Pharm"},{"issue":"4","key":"2744_CR26","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3109\/10837450.2013.795169","volume":"19","author":"MK Shah","year":"2014","unstructured":"Shah MK, Madan P, Lin S (2014) Preparation, in vitro evaluation and statistical optimization of carvedilol-loaded solid lipid nanoparticles for lymphatic absorption via oral administration. Pharm Dev Technol 19(4):475\u2013485","journal-title":"Pharm Dev Technol"},{"issue":"1","key":"2744_CR27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0021-9150(99)00289-0","volume":"149","author":"MM Van Greevenbroek","year":"2000","unstructured":"Van Greevenbroek MM, Erkelens DW, de Bruin TW (2000) Caco-2 cells secrete two independent classes of lipoproteins with distinct density: effect of the ratio of unsaturated to saturated fatty acid. Atherosclerosis 149(1):25\u201331","journal-title":"Atherosclerosis"},{"issue":"8","key":"2744_CR28","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1002\/1520-6017(200008)89:8<1073::AID-JPS12>3.0.CO;2-V","volume":"89","author":"SM Caliph","year":"2000","unstructured":"Caliph SM, Charman WN, Porter CJ (2000) Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats. J Pharm Sci 89(8):1073\u20131084","journal-title":"J Pharm Sci"}],"container-title":["Nanoscale Research Letters"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s11671-018-2744-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s11671-018-2744-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s11671-018-2744-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T00:36:41Z","timestamp":1679272601000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s11671-018-2744-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,15]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2744"],"URL":"https:\/\/doi.org\/10.1186\/s11671-018-2744-6","relation":{},"ISSN":["1931-7573","1556-276X"],"issn-type":[{"value":"1931-7573","type":"print"},{"value":"1556-276X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,15]]},"assertion":[{"value":"27 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"323"}}